Cargando…
Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial
BACKGROUND: Osteoporosis (OP) and osteoarthritis (OA) are prevalent skeletal disorders among postmenopausal women. Coexistence is common especially that of postmenopausal osteoporosis (PMO) and lumbar OA. An hypothesis has been raised that OP and OA might share the same pathogenic mechanism, and pul...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482283/ https://www.ncbi.nlm.nih.gov/pubmed/26058489 http://dx.doi.org/10.1186/s13063-015-0780-4 |
_version_ | 1782378413708804096 |
---|---|
author | Liu, Hui-Fang He, Hong-Chen Yang, Lin Yang, Zhou-Yuan Yao, Ke Wu, Yuan-Chao Yang, Xi-Biao He, Cheng-Qi |
author_facet | Liu, Hui-Fang He, Hong-Chen Yang, Lin Yang, Zhou-Yuan Yao, Ke Wu, Yuan-Chao Yang, Xi-Biao He, Cheng-Qi |
author_sort | Liu, Hui-Fang |
collection | PubMed |
description | BACKGROUND: Osteoporosis (OP) and osteoarthritis (OA) are prevalent skeletal disorders among postmenopausal women. Coexistence is common especially that of postmenopausal osteoporosis (PMO) and lumbar OA. An hypothesis has been raised that OP and OA might share the same pathogenic mechanism, and pulsed electromagnetic fields (PEMFs) were reported to have anti-osteoporosis and anti-osteoarthritis properties, but this suggestion was based primarily on biomarker data. Therefore, whether these two effects could take place simultaneously has not yet been investigated. This randomized controlled trial (RCT) is designed to explore the effect of PEMFs for PMO and concomitant lumbar OA. METHODS/DESIGN: The study will include PMO patients (postmenopausal women; aged between 50 and 70 years; have been postmenopausal for at least 5 years and diagnosed with OP using proximal femur T-score) with concomitant lumbar OA (patients with confounding disorders like diabetes, hypertension, hyperlipidemia, and previous fracture history, etcetera, will be excluded) will be randomly assigned to two arms: PEMFs group and sham PEMFs group. There will be 25 participants in each arm (50 in total) and the outcome assessment, including the primary endpoint (proximal femur bone mineral density), will be performed at 5 weeks, 3 months and 6 months after enrollment. DISCUSSION: PMO and lumbar OA are prominent public health problem, especially for postmenopausal women. We hope this RCT will provide scientific evidence to primary care of the postmenopausal women regarding the use of these nonpharmaceutical, noninvasive modalities, PEMFs, in managing PMO and lumbar OA. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR-TRC-14005156 (28 August 2014). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0780-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4482283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44822832015-06-27 Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial Liu, Hui-Fang He, Hong-Chen Yang, Lin Yang, Zhou-Yuan Yao, Ke Wu, Yuan-Chao Yang, Xi-Biao He, Cheng-Qi Trials Study Protocol BACKGROUND: Osteoporosis (OP) and osteoarthritis (OA) are prevalent skeletal disorders among postmenopausal women. Coexistence is common especially that of postmenopausal osteoporosis (PMO) and lumbar OA. An hypothesis has been raised that OP and OA might share the same pathogenic mechanism, and pulsed electromagnetic fields (PEMFs) were reported to have anti-osteoporosis and anti-osteoarthritis properties, but this suggestion was based primarily on biomarker data. Therefore, whether these two effects could take place simultaneously has not yet been investigated. This randomized controlled trial (RCT) is designed to explore the effect of PEMFs for PMO and concomitant lumbar OA. METHODS/DESIGN: The study will include PMO patients (postmenopausal women; aged between 50 and 70 years; have been postmenopausal for at least 5 years and diagnosed with OP using proximal femur T-score) with concomitant lumbar OA (patients with confounding disorders like diabetes, hypertension, hyperlipidemia, and previous fracture history, etcetera, will be excluded) will be randomly assigned to two arms: PEMFs group and sham PEMFs group. There will be 25 participants in each arm (50 in total) and the outcome assessment, including the primary endpoint (proximal femur bone mineral density), will be performed at 5 weeks, 3 months and 6 months after enrollment. DISCUSSION: PMO and lumbar OA are prominent public health problem, especially for postmenopausal women. We hope this RCT will provide scientific evidence to primary care of the postmenopausal women regarding the use of these nonpharmaceutical, noninvasive modalities, PEMFs, in managing PMO and lumbar OA. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR-TRC-14005156 (28 August 2014). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0780-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-10 /pmc/articles/PMC4482283/ /pubmed/26058489 http://dx.doi.org/10.1186/s13063-015-0780-4 Text en © Liu et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Liu, Hui-Fang He, Hong-Chen Yang, Lin Yang, Zhou-Yuan Yao, Ke Wu, Yuan-Chao Yang, Xi-Biao He, Cheng-Qi Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
title | Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
title_full | Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
title_fullStr | Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
title_full_unstemmed | Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
title_short | Pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest China using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
title_sort | pulsed electromagnetic fields for postmenopausal osteoporosis and concomitant lumbar osteoarthritis in southwest china using proximal femur bone mineral density as the primary endpoint: study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482283/ https://www.ncbi.nlm.nih.gov/pubmed/26058489 http://dx.doi.org/10.1186/s13063-015-0780-4 |
work_keys_str_mv | AT liuhuifang pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT hehongchen pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT yanglin pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT yangzhouyuan pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT yaoke pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT wuyuanchao pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT yangxibiao pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial AT hechengqi pulsedelectromagneticfieldsforpostmenopausalosteoporosisandconcomitantlumbarosteoarthritisinsouthwestchinausingproximalfemurbonemineraldensityastheprimaryendpointstudyprotocolforarandomizedcontrolledtrial |